These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anxiety and depression associated with a positive prostate biopsy result: A comparative, prospective cohort study. Sefik E; Gunlusoy B; Eker A; Celik S; Ceylan Y; Koskderelioglu A; Basmaci I; Degirmenci T Int Braz J Urol; 2020; 46(6):993-1005. PubMed ID: 32822128 [TBL] [Abstract][Full Text] [Related]
4. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272 [TBL] [Abstract][Full Text] [Related]
5. Prospective analysis of psychological distress in men being investigated for prostate cancer. Jadhav SA; Sukumar S; Kumar G; Bhat SH Indian J Urol; 2010 Oct; 26(4):490-3. PubMed ID: 21369377 [TBL] [Abstract][Full Text] [Related]
6. The measurement of psychological distress in men being investigated for the presence of prostate cancer. Awsare NS; Green JS; Aldwinckle B; Hanbury DC; Boustead GB; McNicholas TA Prostate Cancer Prostatic Dis; 2008; 11(4):384-9. PubMed ID: 18427569 [TBL] [Abstract][Full Text] [Related]
8. The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. Nelson CJ; Mulhall JP; Roth AJ J Sex Med; 2011 Feb; 8(2):560-6. PubMed ID: 21155979 [TBL] [Abstract][Full Text] [Related]
9. Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy. Kobayashi M; Nukui A; Kamai T Int J Clin Oncol; 2017 Feb; 22(1):174-180. PubMed ID: 27631094 [TBL] [Abstract][Full Text] [Related]
10. The psychological impact of prostate biopsy: Prevalence and predictors of procedure-related distress. Sharp L; Morgan E; Drummond FJ; Gavin A Psychooncology; 2018 Feb; 27(2):500-507. PubMed ID: 28766309 [TBL] [Abstract][Full Text] [Related]
11. Psychological distress among patients awaiting histopathologic results after prostate biopsy: An unaddressed concern. Sarchi L; Eissa A; Puliatti S; Amato M; Assumma S; Calcagnile T; Ticonosco M; Iseppi A; Toso S; Sighinolfi MC; Bianchi G; Micali S; Rocco B Urologia; 2022 Aug; 89(3):382-387. PubMed ID: 34612746 [TBL] [Abstract][Full Text] [Related]
12. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR; Evans WP; Borden JD; Castellanos RD Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040 [TBL] [Abstract][Full Text] [Related]
13. The prevalence and predictors of psychological distress in patients with early localized prostate cancer. Bisson JI; Chubb HL; Bennett S; Mason M; Jones D; Kynaston H BJU Int; 2002 Jul; 90(1):56-61. PubMed ID: 12081771 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years. Goldberg H; Klaassen Z; Chandrasekar T; Wallis CJD; Toi A; Sayyid R; Bhindi B; Nesbitt M; Evans A; van der Kwast T; Sweet J; Perlis N; Hamilton RJ; Kulkarni GS; Finelli A; Zlotta A; Fleshner N J Urol; 2018 Nov; 200(5):1056-1061. PubMed ID: 29758220 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. Klotz L; Chin J; Black PC; Finelli A; Anidjar M; Bladou F; Mercado A; Levental M; Ghai S; Chang SD; Milot L; Patel C; Kassam Z; Moore C; Kasivisvanathan V; Loblaw A; Kebabdjian M; Earle CC; Pond GR; Haider MA JAMA Oncol; 2021 Apr; 7(4):534-542. PubMed ID: 33538782 [TBL] [Abstract][Full Text] [Related]
16. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. Potts JM J Urol; 2000 Nov; 164(5):1550-3. PubMed ID: 11025702 [TBL] [Abstract][Full Text] [Related]
17. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related]
18. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required? Gerstenbluth RE; Seftel AD; Hampel N; Oefelein MG; Resnick MI J Urol; 2002 Nov; 168(5):1990-3. PubMed ID: 12394692 [TBL] [Abstract][Full Text] [Related]
19. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. Rosario DJ; Lane JA; Metcalfe C; Donovan JL; Doble A; Goodwin L; Davis M; Catto JW; Avery K; Neal DE; Hamdy FC BMJ; 2012 Jan; 344():d7894. PubMed ID: 22232535 [TBL] [Abstract][Full Text] [Related]
20. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy. Nafie S; Wanis M; Khan M Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]